- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04607811
Behavioral Economics and Mobility After Stroke (BE Mobile) (BE Mobile)
September 15, 2021 updated by: University of Pennsylvania
Using Behavioral Economics to Improve Mobility for Adults With Stroke
In this pilot, randomized controlled trial, the investigators will compare the preliminary effectiveness of a gamification with social incentives 8 week intervention to increase physical activity for adults with stroke.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
In this 2 arm randomized trial, the investigators will compare the preliminary effectiveness of a social incentive-based gamification intervention to increase physical activity relative to a control arm among adults with stroke.
All participants will use a Fitbit wearable device to establish a baseline step count, select a step goal increase of 33% to 50% above their baseline and then participate in an 8 week intervention.
The gamification arm will be entered into a game with points and levels designed using insights from behavioral economics.
They will be asked to select a social support partner who will receive weekly updates on their progress in the game.
Study Type
Interventional
Enrollment (Actual)
34
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- University of Pennsylvania
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- History of ischemic or hemorrhagic stroke (confirmed with ICD-10 or DRG code) at least 3 months prior to enrollment
- Ability to provide informed consent
- Life Space Assessment mobility level 3
- Ability to ambulate outside of their home (self-reported)
- Owns a smartphone or tablet compatible with required applications for the wearable tracking device
- Sufficient cognitive ability to participate (5-minute Montreal Cognitive Assessment Score ≥ 11 points)
Exclusion Criteria:
- Inability to provide informed consent, illiteracy or inability to speak, read, and write English
- Self-reported history of falls within the last 3 months
- Severe cognitive impairment (MoCA score ≤ 10 points)
- Medical condition that may limit participation in physical activity program (e.g. metastatic cancer, end-stage renal disease)
- Currently institutionalized in skilled nursing or long-term care facility
- Baseline step count > 7500/day
- Currently receiving physical therapy services
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control arm
Participants will wear the Fitbit device and record their daily step counts during the baseline and 8 week intervention period.
Participants will complete study surveys at baseline and the end of the 8 week intervention.
|
|
|
Experimental: Gamification arm
Participants will wear the Fitbit device and record their daily step counts during the baseline and 8 week intervention period.
Participants will have a weekly step goal they are encouraged to meet.
Participants will engage in a social incentive-based gamification based on points and levels that leverages loss aversion, which has been demonstrated to motivate behavior change more effectively with losses than gains.
Participants will receive daily feedback for the step counts and weekly feedback for levels.
Participants will be asked to identify a support partner, who will receive weekly reports with the the participant's points and levels balance.
|
Participants will select a step goal that is 33%, 40%, or 50% above their baseline step value.
Participants in this group will participate in a game with points and levels to help motivate participants to meet their daily step goal.
Additionally, all participants will identify a support partner to receive weekly updates on their performance and offer positive encouragement to help the participant meet their step goal.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Daily step counts
Time Frame: Intervention weeks 1-8
|
Change in mean daily steps from baseline
|
Intervention weeks 1-8
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Daily step counts
Time Frame: Intervention weeks 1-8
|
Proportion of days participants in the gamification arm met their daily step goal
|
Intervention weeks 1-8
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Kimberly J Waddell, PhD, MS, University of Pennsylvania
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 16, 2020
Primary Completion (Actual)
July 12, 2021
Study Completion (Actual)
July 12, 2021
Study Registration Dates
First Submitted
October 22, 2020
First Submitted That Met QC Criteria
October 22, 2020
First Posted (Actual)
October 29, 2020
Study Record Updates
Last Update Posted (Actual)
September 16, 2021
Last Update Submitted That Met QC Criteria
September 15, 2021
Last Verified
September 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 843894
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
University Hospital HeidelbergCompletedAcute Ischemic Stroke | Acute Ischemic Stroke AIS | Acute Ischemic Stroke PatientsGermany
Clinical Trials on Gamification with social incentives
-
Abramson Cancer Center at Penn MedicineNational Heart, Lung, and Blood Institute (NHLBI)CompletedPhysical ActivityUnited States
-
University of PennsylvaniaCompletedPeripheral Artery DiseaseUnited States
-
University of PennsylvaniaNational Institute on Aging (NIA)WithdrawnCardiovascular DiseasesUnited States
-
University of PennsylvaniaNational Heart, Lung, and Blood Institute (NHLBI)RecruitingHFpEF - Heart Failure With Preserved Ejection FractionUnited States
-
University of PennsylvaniaNational Institute on Aging (NIA)Active, not recruitingHeart Failure | Hypertension | Diabetes | Mobility Limitation | Ambulatory DifficultyUnited States
-
University of PennsylvaniaCompletedBladder CancerUnited States
-
The University of Hong KongUniversity Grants Committee, Hong KongCompletedDiabetes Mellitus, Type 2Hong Kong
-
Abramson Cancer Center at Penn MedicineAmerican Heart Association; City of Hope National Medical CenterCompletedCardiovascular Diseases | Breast Cancer | Prostate Cancer | Physical InactivityUnited States
-
VA Office of Research and DevelopmentActive, not recruiting
-
The University of Hong KongUniversity Grants Committee, Hong KongCompletedDiabetes Mellitus, Type 2Hong Kong